Similar articles

• Long-term clinical results after coronary artery bypass surgery.

  Bourassa MG. Bourassa MG. Cardiovasc Clin. 1991;21(2):101-21. Cardiovasc Clin. 1991. PMID: 2044085 Review. No abstract available.
• Coronary risk factors and the postbypass patient.

  Campeau L. Campeau L. Cardiovasc Clin. 1991;21(2):123-33. Cardiovasc Clin. 1991. PMID: 2044086 Review.
• Reoperation for coronary artery bypass grafting.

  Carrier M, Perreault L, Pelletier LC. Carrier M, et al. Cardiovasc Clin. 1991;21(2):257-63. Cardiovasc Clin. 1991. PMID: 2044093 No abstract available.
• A very late stent thrombosis in a patient with diabetes: a call for lifelong dual anti-platelet therapy.

  Pecot CV, Fuller M, Muldowney JA 3rd, Misra S. Pecot CV, et al. Tenn Med. 2009 May;102(5):37-9. Tenn Med. 2009. PMID: 19456028 No abstract available.
• Effect of metoprolol on death and cardiac events during a 2-year period after coronary artery bypass grafting. The MACB Study Group.

  [No authors listed] [No authors listed] Eur Heart J. 1995 Dec;16(12):1825-32. Eur Heart J. 1995. PMID: 8682014 Clinical Trial.